China Pharma (00570) Issues Profit Warning, Predicts RMB 0.8-0.85B Loss for H1 2026

CHINA TCM-3.84%
According to a company announcement, China Pharma Holdings (00570) reported an expected loss of approximately RMB 0.8 billion to 0.85 billion for the six months ended June 30, 2026, compared to a loss of RMB 0.142 billion in the same period last year. The widened loss was attributed to reduced sales and profitability in its Chinese herbal granule business due to policy adjustments and market changes, declining revenue in its Chinese patent medicine and herbal material production segments, and increased asset impairment provisions and tax adjustments.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments